Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus
1999495 citationsMary V. Relling, M L Hancock et al.JNCI Journal of the National Cancer Instituteprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of R. C. Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. C. Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. C. Ribeiro more than expected).
This network shows the impact of papers produced by R. C. Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. C. Ribeiro. The network helps show where R. C. Ribeiro may publish in the future.
Co-authorship network of co-authors of R. C. Ribeiro
This figure shows the co-authorship network connecting the top 25 collaborators of R. C. Ribeiro.
A scholar is included among the top collaborators of R. C. Ribeiro based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R. C. Ribeiro. R. C. Ribeiro is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Pinto, Emília M., R. C. Ribeiro, Bonald C. Figueiredo, & Gerard P. Zambetti. (2011). TP53-Associated Pediatric Malignancies. Genes & Cancer. 2(4). 485–490.28 indexed citations
Kaspers, Gertjan J.L., Ursula Creutzig, Gudrun Fleischhack, et al.. (2001). A randomised phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia.1 indexed citations
Relling, Mary V., M L Hancock, Gaston K. Rivera, et al.. (1999). Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus. JNCI Journal of the National Cancer Institute. 91(23). 2001–2008.495 indexed citations breakdown →
12.
Broniscer, Alberto, R. C. Ribeiro, R V Srinivas, et al.. (1996). An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine.. PubMed. 10(7). 1244–8.5 indexed citations
Callen, David F., Bryone J. Kuss, J R Downing, et al.. (1993). Identification of an inversion 16 coexisting with an isochromosome 22q by in situ hybridization in a case of childhood AML M4e.. PubMed. 7(10). 1658–62.6 indexed citations
Rivera, Gaston K., CH Pui, M L Hancock, et al.. (1992). Update of St Jude Study XI for childhood acute lymphoblastic leukemia.. PubMed. 6 Suppl 2. 153–6.9 indexed citations
17.
Ribeiro, R. C., CH Pui, M L Hancock, et al.. (1991). Secondary non-Hodgkin's lymphoma after treatment for childhood cancer.. PubMed. 5(10). 908–11.16 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.